GLP-1 receptor agonists and ischemic optic neuropathy in patients with type 2 diabetes and obesity: A TriNetX cohort study. // AJO International. – URL: https://www.sciencedirect.com/science/article/pii/S2950253526000523?dgcid=rss_sd_all
GLP-1 receptor agonists and ischemic optic neuropathy in patients with type 2 diabetes and obesity: A TriNetX cohort study. AJO International. https://www.sciencedirect.com/science/article/pii/S2950253526000523?dgcid=rss_sd_all
“GLP-1 receptor agonists and ischemic optic neuropathy in patients with type 2 diabetes and obesity: A TriNetX cohort study.” AJO International.
@article{article88277,
title = {GLP-1 receptor agonists and ischemic optic neuropathy in patients with type 2 diabetes and obesity: A TriNetX cohort study},
journal = {AJO International},
url = {https://www.sciencedirect.com/science/article/pii/S2950253526000523?dgcid=rss_sd_all}
}